Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Deferred Taxes (2021 - 2025)

Historic Deferred Taxes for Veracyte (VCYT) over the last 5 years, with Q3 2025 value amounting to -$87000.0.

  • Veracyte's Deferred Taxes fell 56923.08% to -$87000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$256000.0, marking a year-over-year increase of 9165.58%. This contributed to the annual value of -$233000.0 for FY2024, which is 9405.76% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Deferred Taxes is -$87000.0, which was down 56923.08% from $59000.0 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Deferred Taxes ranged from a high of $143000.0 in Q2 2024 and a low of -$3.8 million during Q1 2021
  • Over the past 5 years, Veracyte's median Deferred Taxes value was -$136000.0 (recorded in 2021), while the average stood at -$602888.9.
  • Within the past 5 years, the most significant YoY rise in Veracyte's Deferred Taxes was 20869.57% (2023), while the steepest drop was 186050.96% (2023).
  • Quarter analysis of 5 years shows Veracyte's Deferred Taxes stood at -$961000.0 in 2021, then surged by 83.66% to -$157000.0 in 2022, then plummeted by 1860.51% to -$3.1 million in 2023, then surged by 92.11% to -$243000.0 in 2024, then soared by 64.2% to -$87000.0 in 2025.
  • Its Deferred Taxes stands at -$87000.0 for Q3 2025, versus $59000.0 for Q2 2025 and $15000.0 for Q1 2025.